"Center for Clinical Studies conducts clinical trials for skin related conditions, such as Psoriasis and Psoriatic Arthritis, Eczema (Atopic Dermatitis), Shingles, Acne, Prurigo Nodularis, and more. We enroll qualified participants throughout the Houston, Texas area for our two offices located in the Museum District and Webster, TX. To learn more about our currently enrolling clinical trials, call us at 281-343-3300."

During the past decade, Center for Clinical Studies conducted 75 clinical trials. In the 10-year time frame, 75 clinical trials started and 67 clinical trials were completed, i.e. on average, 89.3% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 40 clinical trials were completed. i.e. 105.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Center for Clinical Studies" #1 sponsor was "Pfizer" with 19 trials, followed by "Amgen" with 11 trials sponsored, "Eli Lilly and Company" with 10 trials sponsored, "LEO Pharma" with 8 trials sponsored and "Galderma R&D" with 8 trials sponsored. Other sponsors include 67 different institutions and companies that sponsored additional 53 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Clinical Studies" #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator, "Prosoft Clinical" with 3 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Athenex, Inc." with 1 trials as a collaborator and "Basilea Pharmaceutica" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Center for Clinical Studies" are "Psoriasis" (26 trials), "Atopic Dermatitis" (23 trials), "Plaque Psoriasis" (18 trials), "Dermatitis, Atopic" (7 trials) and "Acne Vulgaris" (5 trials). Many other conditions were trialed in "Center for Clinical Studies" in a lesser frequency.

Most popular intervention types in "Center for Clinical Studies" are "Drug" (111 trials), "Biological" (14 trials), "Other" (13 trials), "Procedure" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (49 trials), "Vehicle" (7 trials), "Apremilast" (6 trials), "Lebrikizumab" (5 trials) and "Adalimumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Center for Clinical Studies" are 126 trials for "All" genders.

Currently, there are NaN active trials in "Center for Clinical Studies". undefined are not yet recruiting, 7 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 93 completed trials in Center for Clinical Studies, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Center for Clinical Studies, 10 "Phase 1" clinical trials were conducted, 49 "Phase 2" clinical trials and 56 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 3 trials that are defined as “Not Applicable".